Skip to main content

Table 1 Outcomes and assessment measures used in the EMPOWER trial

From: The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trial

Outcomes

Assessment measure

Pre CRT

Mid chemo-CRT

Mid CRT

Week 0

Week 3

Week 6

Week 9

Day 3 post-surgery

Day 5 post-surgery

Day 8 post-surgery

Day 15 post-surgery

6 Weeks post-surgery

Primary endpoint

             

Oxygen uptake at lactate threshold

CPET

X

UHS only

 

X

X

X

X

     

Secondary endpoint

             

Health-related quality of life

Questionnaires: EORTC QLQ-30, EQ-5D

X

UHS only

X

X

X

X

X

    

X

 

Semi-structured interviews

   

X

  

X

     

Physical activity

SenseWear accelerometer

X

UHS only

X

X

X

X

X

     

Exploratory endpoint

             

Post-operative morbidity

POMS

       

X

X

X

X

 

Cancer staging

MR pelvis mrTRG

X

     

X

     

X

  1. Abbreviations: CRT chemoradiotherapy, CPET cardiopulmonary exercise test, UHS University Hospital Southampton, POMS Post- operative morbidity score, mrTRG magnetic resonance tumour regression grade, MR magnetic resonance